arrow
Back
J

Jae‐Lyun Lee

university of ulsan

66H-index
641Paper Count
2.6WCitation Count
Published Papers 127
Publication Date
A Multicenter Phase II Study of Modified FOLFIRINOX for First-Line Treatment for Advanced Urachal Cancer (ULTIMA; KCSG GU20-03)
err2026-01-01
err3
errOAAI
errPark, Inkeun; Lee, Jae Lyun; Yoon, Shinkyo; Shin, Sang Joon; Shin, Seong-Hoon; Kim, Jung Hoon; Park, Kwonoh; Lee, Hyo Jin
errShare
errSave
Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma
err2025-12-03
err0
errOAAI
errSojin Kim; Shinkyo Yoon; Inkeun Park; Jae Lyun Lee; Hyehyun Jeong; Yousun Ko; Kyung Won Kim; Sun Young Kim
errShare
errSave
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
err2025-10-27
err0
PREAI
errMatthew Smith; Josep Piulats; Tilman Todenhöfer; Jae-Lyun Lee; José Arranz Arija; Laura Mazilu; Arun Azad; Teresa Alonso-Gordoa; Ursula McGovern; Atish Choudhury; Lisa Horvath; Dingwei Ye; Weiqing Han; Hiroyoshi Suzuki; Hiroji Uemura; Rana McKay; Steven Ades; Aude Fléchon; Christopher Pieczonka; Maria S Fernandes; Maarten Hulstijn; Andrew Lithio; Karim Nacerddine; Neeraj Agarwal
errShare
errSave
Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-Line Platinum-Based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05)
err2025-10-01
err0
errOAAI
errPark, Inkeun; Yoon, Shinkyo; Kim, Ilhwan; Park, Kwonoh; Lee, Suee; Keam, Bhumsuk; Park, Joo-Hwan; Kim, Jin Young; Choi, Yoon Ji; Sohn, Byeong Seok; Lee, Jae Lyun
errShare
errSave
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
err2025-10-01
err10
PREAI
errPowles, Thomas; Kann, Ariel G.; Castellano, Daniel; Gross-Goupil, Marine; Nishiyama, Hiroyuki; Bracarda, Sergio; Bjerggaard Jensen, Jorgen; Makaroff, Lydia; Jiang, Shusuan; Ku, Ja Hyeon; Park, Se Hoon; Reig Torras, Oscar; Ye, Dingwei; Maruzzo, Marco; Necchi, Andrea; Morales-Barrera, Rafael; Giunta, Emilio Francesco; Lee, Jae Lyun; Tortora, Giampaolo; Urun, Yuksel; Dolowy, Lukasz; Erdem, Dilek; Pinto, Alvaro; Grando, Fabricio; Zou, Wei; Assaf, Zoe June; Vuky, Jacqueline; Degaonkar, Viraj; Steinberg, Elizabeth E.; Bellmunt, Joaquim; Gschwend, Jurgen E.
errShare
errSave
Combination casdatifan plus cabozantinib in previously treated patients with clear cell renal cell carcinoma: results from an expansion cohort of ARC-20 (NCT05536141)
err2025-10-01
err0
errOAAI
errChoueri, Toni; Ornstein, Moshe; Barata, Pedro C.; Matrana, Marc; Merchan, Jaime; Gedye, Craig; Hwang, Clara; Kumar, Rohit; Lee, Jae Lyun; Guan, Yinghui; Ghasemi, Mohammad; Quadri, Syed; Negro, Chris; Chen, Jianfen; Foster, Paul; Warad, Deepti; McGregor, Bradley A.; Rha, Sun Young; Drakaki, Alexandra
errShare
errSave
Clinical characteristics, determinants and subsequent therapy of primary refractory metastatic renal cell carcinoma (mRCC): an international metastatic database consortium (IMDC) study
err2025-10-01
err0
errOAAI
errEid, Marc; Semaan, Karl; Xie, Wanling; Chehade, Razane El Hajj; Ascione, Liliana; Maj, David; Zarba, Martin; Wells, J. Connor; Wood, Laura; Tran, Ben; Angel, Martin; Pal, Sumanta K.; Lee, Jae-Lyun; Takemura, Kosuke; Kollmannsberger, Christian K.; Templeton, Arnoud J.; Bjarnason, Georg A.; Ruiz, Jose Manuel; Heng, Daniel; Choueiri, Toni K.
errShare
errSave
Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study
err2025-10-01
err2
errOAAI
errAlbiges, Laurence; Gurney, Howard; Lee, Jae Lyun; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A.; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Gedye, Craig; Lacombe, Louis; Ferguson, Thomas; Stus, Viktor; Wiechno, Pawel; Erman, Mustafa; Urun, Yuksel; Cornell, Jerry; Burgents, Joe; Sharma, Manish; Voss, Martin
errShare
errSave
First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial
err2025-07-24
err0
PREAI
errMartin H. Voss; Howard Gurney; Vagif Atduev; Cristina Suarez; Miguel A. Climent; David Pook; Piotr Tomczak; Philippe Barthélémy; Jae Lyun Lee; Taron Nalbandian; Viktor Stus; Thomas Ferguson; Pawel Wiechno; Erhan Gokmen; Louis Lacombe; Craig Gedye; Jerry Cornell; Manish Sharma; Joseph E. Burgents; Laurence Albiges
errShare
errSave
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study
err2025-05-28
err0
PREAI
errShilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
errShare
errSave
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bisceglia criteria
err2025-04-30
err0
errOAAI
errByung-Chang Kim; HyeJin Han; Douk Kwon; Shin Jeong Pak; Hyeong Rok An; Won Woong Kim; Yu-Mi Lee; Seung Hun Lee; Jung-Min Koh; Jae Lyun Lee; Ki-Wook Chung; Dong Eun Song; Tae-Yon Sung
errShare
errSave
First-In-Human Dose Finding Study of Venadaparib (IDX-1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors
err2025-02-13
err0
errOAAI
errKim, Sung-Bae; Bae, Kyun-Seop; Lee, Jae Lyun; Lee, Won Sik; Ock, Chan-Young; Lee, Myong-Jae; Bang, Jeongsook; Hong, Min Ju; Roh, Eun-Jihn; Ha, Kyoung Soo; Lim, Jong-Ha; Kim, Yong-Man
errShare
errSave
Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis
err2025-02-01
err1
PREAI
errGupta, Mehul; Wells, Connor; Regan, Meredith M.; Xie, Wanling; Navani, Vishal; Saliby, Renee Maria; Basa, Naveen S.; Donskov, Frede; Yuasa, Takeshi; Takemura, Kosuke; Kollmannsberger, Christian K.; Crumbaker, Megan; Lalani, Aly-Khan A.; Powles, Thomas; Ebrahimi, Hedyeh; Mckay, Rana R.; Lee, Jae-Lyun; Kanesvaran, Ravindran; Choueiri, Toni K.; Heng, Daniel Y. C.
errShare
errSave
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial
err2024-12-30
err0
errOAAI
errGruenwald, Viktor; Mckay, Rana R.; Buchler, Tomas; Eto, Masatoshi; Park, Se Hoon; Takagi, Toshio; Zanetta, Sylvie; Keizman, Daniel; Suarez, Cristina; Negrier, Sylvie; Lee, Jae Lyun; Santini, Daniele; Bedke, Jens; Staehler, Michael; Kollmannsberger, Christian; Choueiri, Toni K.; Motzer, Robert J.; Burgents, Joseph E.; Xie, Ran; Okpara, Chinyere E.; Powles, Thomas
errShare
errSave
Impact of Prior Chemotherapy on Response to Second-line Pembrolizumab in Urothelial Cancer: Exploratory Analysis of the Phase 3 KEYNOTE-045 Trial
err2024-08-22
err0
PREAI
errRonald de Wit; David J. Vaughn; Yves Fradet; Lawrence Fong; Miguel A. Climent; Andrea Necchi; Daniel P. Petrylak; Winald R. Gerritsen; Howard Gurney; David I. Quinn; Stéphane Culine; Cora N. Sternberg; Dean F. Bajorin; Toni K. Choueiri; Jin Xu; Kentaro Imai; Blanca Homet Moreno; Joaquim Bellmunt; Jae-Lyun Lee
errShare
errSave
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
err2024-08-22
err5
PREAI
errChoueiri, T. K.; Powles, T.; Peltola, K.; de Velasco, G.; Burotto, M.; Suarez, C.; Ghatalia, P.; Iacovelli, R.; Lam, E. T.; Verzoni, E.; Gumus, M.; Stadler, W. M.; Kollmannsberger, C.; Melichar, B.; Venugopal, B.; Gross-Goupil, M.; Poprach, A.; De Santis, M.; Schutz, F. A.; Park, S. H.; Nosov, D. A.; Porta, C.; Lee, J. L.; Garcia-del-Muro, X.; Biscaldi, E.; Kopp, R. Manneh; Oya, M.; He, L.; Wang, A.; Perini, R. F.; Vickery, D.; Albiges, L.; Rini, B.
errShare
errSave
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302)
err2024-07-25
err1
errOAAI
errLara Jr, Primo N.; Villanueva, Luis; Ibanez, Carolina; Erman, Mustafa; Lee, Jae Lyun; Heinrich, Daniel; Lipatov, Oleg Nikolaevich; Gedye, Craig; Gokmen, Erhan; Acevedo, Alejandro; Semenov, Andrey; Park, Se Hoon; Gafanov, Rustem Airatovich; Kose, Fatih; Jones, Mark; Du, Xiaoqi; Munteanu, Mihaela; Perini, Rodolfo; Choueiri, Toni K.; Motzer, Robert J.
errShare
errSave
Comparison of digital and analog [68Ga]Ga-PSMA-11 PET/CT for detecting post-prostatectomy biochemical recurrence in prostate cancer patients: a prospective study
err2024-07-01
err2
errOAAI
errKim, Yong-il; Lee, Dong Yun; Sung, Changhwan; Lee, Sang Ju; Oh, Seung Jun; Oh, Jungsu S.; Yoon, Shinkyo; Lee, Jae Lyun; Lim, Bumjin; Suh, Jungyo; Park, Juhyun; You, Dalsan; Jeong, In Gab; Hong, Jun Hyuk; Ahn, Hanjong; Kim, Choung-Soo; Ryu, Jin-Sook
errShare
errSave
Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program
err2024-06-03
err2
errOAAI
errPark, Se Hoon; Shin, Sang Joon; Rha, Sun Young; Beom, Seung-Hoon; Seo, Ho Kyung; Keam, Bhumsuk; Kim, Miso; Hong, Yoon-Hee; Yoon, Shinkyo; Lee, Jae-Lyun
errShare
errSave